Patents by Inventor Ming-Kang LEE

Ming-Kang LEE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250105140
    Abstract: A method for manufacturing a semiconductor device includes: forming a plurality of sacrificial stack portions on a semiconductor substrate, the sacrificial stack portions being spaced apart from each other; forming a metal material layer to cover the sacrificial stack portions, the metal material layer including a first metal and a second metal different from the first metal, the first metal having a reduction potential lower than that of the second metal; and annealing the metal material layer to form a self-forming barrier layer conformally covering the sacrificial stack portions, the self-forming barrier layer including a metal oxide, a metal silicide, or a combination thereof formed from the first metal by annealing.
    Type: Application
    Filed: September 26, 2023
    Publication date: March 27, 2025
    Applicant: Taiwan Semiconductor Manufacturing Company, Ltd.
    Inventors: Shih-Kang FU, Hsien-Chang WU, Ming-Han LEE
  • Publication number: 20250096140
    Abstract: An interconnect structure, along with methods of forming such, are described. The structure includes a dielectric layer, a conductive feature disposed in the dielectric layer, and a conductive layer disposed over the dielectric layer, wherein the conductive layer includes a first portion and a second portion adjacent the first portion. The structure also includes a first barrier layer in contact with the first portion of the conductive layer, a second barrier layer in contact with the second portion of the conductive layer, and a dielectric material disposed between and in contact with the first and second barrier layers, wherein a bottom surface of the second barrier layer and a bottom surface of the dielectric material are substantially co-planar.
    Type: Application
    Filed: September 17, 2023
    Publication date: March 20, 2025
    Inventors: Hsien-Chang WU, Shih-Kang FU, Shin-Yi YANG, Gary LIU, Ting-Ya LO, Ming-Han LEE
  • Publication number: 20250038025
    Abstract: The present invention provides a wafer container and a gas diffusion device applied in the wafer container. The wafer container includes a shell, and all components included and applied on the shell are made of thermal resistance materials. The gas diffusion device and the wafer container, when assembled together, utilize a coupling structure and a collar as a protection mechanism for the gas diffusion device. The gas diffusion device has a buffering chamber that provides a buffering tolerance and a communicating space for the gas before the gas enters an interior space of the wafer container.
    Type: Application
    Filed: October 17, 2024
    Publication date: January 30, 2025
    Inventors: Ming-Chien Chiu, Chia-Ho Chuang, Kuo-Hua Lee, Shu-Hung Lin, Hao-Kang Hsia
  • Patent number: 12205886
    Abstract: The present disclosure provides a semiconductor device that includes a substrate, a first dielectric layer over the substrate, and an interconnect layer over the first dielectric layer. The interconnect layer includes a plurality of metal lines and a second dielectric layer filling space between the plurality of metal lines. The plurality of metal lines includes a first metal line having a first bulk metal layer of a noble metal and a second metal line having a second bulk metal layer of a non-noble metal.
    Type: Grant
    Filed: July 26, 2022
    Date of Patent: January 21, 2025
    Assignee: TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD.
    Inventors: Shih-Kang Fu, Ming-Han Lee, Shau-Lin Shue
  • Publication number: 20240316061
    Abstract: Methods and pharmaceutical compositions for the treatment of BAP1 deficient cancer are based on investigation of the role of BET (Bromodomain and Extra-Terminal motif proteins) in BAP1 deficient cancer and screened isogenic cells (BAP1 WT vs KO). BET inhibitors show more anti-proliferative activity against cells KO for BAP1. Using isogenic cell lines and uveal melanoma PDX derived cell lines with different status of expression for BAP1 showed a highest dose response to a BET inhibitors (OTX015 and BI894999) in BAP1 KO isogenic cells compared to WT cells and an enhanced dose response to OTX015 in a BAP1 mutated uveal melanoma (UM) derived cells compared to UM cells expressing BAP1. BET inhibitors have a role in BAP1 deficient cancer, and BET inhibitors are useful in the treatment of BAP1 deficient cancer, particularly BAP1 deficient Uveal Melanoma, clear cell Renal Carcinoma, cholangiocarcinoma and mesothelioma.
    Type: Application
    Filed: September 16, 2022
    Publication date: September 26, 2024
    Inventors: Raphaƫl MARGUERON, Ming-Kang LEE